Table 6.6g

Immunosuppression Use for Maintenance Between Discharge

and One Year Following Transplantation, 1994 to 2003

Recipients with Pancreas Transplant Alone (PTA) Transplants

  Year of Transplant
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
Transplants 40 42 52 79 88 137 135 165 177 159
Tx with Follow-up Immunosuppression Info 24 23 30 46 63 107 97 122 138 117
Corticosteroids Any in Category 54.2% 87.0% 96.7% 100.0% 100.0% 100.0% 96.9% 92.6% 87.7% 56.4%
Steroids 54.2% 87.0% 96.7% 100.0% 100.0% 100.0% 96.9% 92.6% 87.7% 56.4%
Cyclosporine Any in Category 50.0% 43.5% 43.3% 23.9% 17.5% 8.4% 8.2% 5.7% 8.7% 7.7%
Cyclosporin 50.0% 17.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sandimmmune 0.0% 8.7% 10.0% 2.2% 0.0% 0.0% 2.1% 0.0% 0.0% 0.9%
Neoral 0.0% 17.4% 33.3% 21.7% 17.5% 8.4% 5.2% 5.7% 6.5% 6.0%
Gengraf 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.0% 0.0% 1.4% 0.9%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 0.0%
Tacrolimus Any in Category 70.8% 56.5% 80.0% 80.4% 96.8% 96.3% 95.9% 98.4% 94.9% 82.9%
Tacrolimus 70.8% 56.5% 80.0% 80.4% 96.8% 96.3% 95.9% 98.4% 94.9% 82.9%
Antimetabolites Any in Category 100.0% 95.7% 93.3% 91.3% 93.7% 92.5% 81.4% 73.8% 65.9% 59.8%
Mycophenolate Mofetil 0.0% 43.5% 80.0% 78.3% 81.0% 89.7% 76.3% 70.5% 65.9% 59.0%
Azathioprine 100.0% 52.2% 13.3% 13.0% 12.7% 2.8% 5.2% 3.3% 0.0% 0.9%
Cytoxan 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.0% 0.0% 0.0% 17.8% 26.8% 16.4% 32.6% 26.5%
Sirolimus 0.0% 0.0% 0.0% 0.0% 0.0% 17.8% 26.8% 16.4% 32.6% 26.5%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

Percentages are calculated based on the total number of patients with any immunosuppression use between discharge and one year following transplantation.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug withinthe same category.